Yale Doc Backing HCQ Cites Questionable Data
Negative results from randomized trials not even acknowledged
Related Articles
Evidence of Resistance to Standard Malaria Therapy for Severe Cases
High levels of drug resistance could require changes in management strategies, one expert says
FDA Plans to Ban Popular Cold Med
Data review shows that oral phenylephrine is not effective as a decongestant, agency says
RFK Jr. Selected to Lead HHS
Vaccine skeptic tapped to run massive agency overseeing everything from drug to food safety
RSV Severity, Deaths on Par With Flu and COVID
Pre-vaccine era data suggest underrecognized burden of disease, especially in older adults
Ian Tannock Cautions About Adjuvant Treatment for High-Risk RCC
Current guidelines from the National Comprehensive Cancer Network for treatment of high-risk renal cell carcinoma (RCC) recommend the use of adjuvant pembrolizumab. However, the authors…
Physicians Rarely Disciplined by Medical Boards for Spreading Misinformation
Editorialists say sanctions should be rare and discipline may be better left to other agencies
Ozempic Linked With Lower Risk of Alzheimer’s Diagnosis
Large observational study suggests further research is warranted